Expert Interview
Discussing the recent part 1b results from the SUMMIT trial evaluating bezuclastinib in iSM (indolent Systemic Mastocytosis) presented at AAAAI
Ticker(s): COGT, BPMCInstitution: Allergy & Asthma Medical Group and Research Center
- Fellowship trained in Allergy & Immunology
- Associate Voluntary Clinical Professor at UCSD in the Division of Allergy/Immunology, and the Co-Director of the Rady Children’s Hospital Allergy Asthma Foundation of America supported Severe Asthma Program as well as Co- Director of the Multidisciplinary Atopic Dermatitis Program at Rady Childrens Hospital
- Current President of the San Diego Allergy Society
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
